What is 7-OH, and is it Dangerous?

In recent years, the compound 7-hydroxymitragynine, commonly referred to as 7-OH, has gained attention due to its presence in kratom and its potential impact on public health. Often marketed in drink mixes, tablets, pills, fruit-flavored gummies, and even sold in vape stores, gas stations, and smoke shops, 7-OH is found in various kratom products and is believed to contribute to the opioid-like effects users experience. But what exactly is 7-OH? Where does it come from, and more importantly, is it dangerous?

This article explores the origins, pharmacology, risks, and legal concerns surrounding 7-OH — particularly within the context of the ongoing opioid crisis and rising health concerns related to unregulated substances.

What is 7-OH?

7-hydroxymitragynine (7-OH) is a naturally occurring indole alkaloid found in the kratom plant (Mitragyna speciosa), a tropical tree native to Southeast Asia.[1] While it is one of over 40 known alkaloids in kratom, 7-OH is particularly potent.

Although it is present in extremely low concentrations in the raw plant, 7-OH is a powerful active metabolite of mitragynine, the most abundant alkaloid in kratom. Through metabolism, particularly in the liver, mitragynine is converted into 7-OH, which binds strongly to opioid receptors, especially the mu-opioid receptor, mimicking the effects of morphine.

Medical and Pharmacological Profile

7-OH’s pharmacology is similar to traditional opioids, leading to analgesic (pain-relieving) and euphoric effects. It exhibits an antinociceptive effect, which makes it attractive to those seeking relief from pain, anxiety, or other ailments.

However, its affinity to opioid receptors raises red flags. It functions as a partial agonist, meaning it activates opioid receptors but not to the same extent as full agonists like heroin or fentanyl. Despite this, the ability of 7-OH to induce opioid-like effects is significant enough to prompt concern from public health authorities.

In some experimental models, 7-OH has shown higher potency than morphine. Studies published in the Journal of Medicinal Chemistry (2016) demonstrated that 7-OH binds to the mu-opioid receptor with approximately 13 times the potency of morphine.[2]

Products Containing 7-OH

Commercial kratom products vary widely in their total alkaloid content, and many are concentrated during processing to enhance the effects. This can lead to high concentrations of 7-OH — far beyond what is naturally present in the plant.

Some products, such as drink mixes and shots, gummies, and even ice cream cones, have been found to contain elevated 7-OH levels, often unlabeled and unregulated. This creates a challenge for consumers who may unknowingly ingest dangerous doses.

Is 7-OH Dangerous?

The danger of 7-OH lies in its potential to mimic opioids without being officially classified as one — at least not consistently across jurisdictions. The Drug Enforcement Administration (DEA) has recognized kratom and its constituents, including 7-OH, as a particular concern. Although not yet federally scheduled under the Controlled Substances Act, the DEA previously proposed classifying mitragynine and 7-OH as Schedule I substances due to abuse potential.

Health Concerns and Adverse Events

According to the FDA (Food and Drug Administration) and the National Institute on Drug Abuse (NIDA), kratom has been linked to multiple adverse events, including:[3]

• Respiratory depression
• Liver toxicity
• Seizures
• Mood disorders
• Opioid withdrawal symptoms 

In 2018, the CDC reported over 90 deaths associated with kratom exposure, though many involved co-ingested substances.[4] Still, the presence of 7-OH in those cases raises questions about its safety profile.

Poison Help Line centers have also received a growing number of calls related to kratom toxicity. In 2021, there were 1,807 kratom exposures reported to U.S. poison centers, according to the American Association of Poison Control Centers.[5]

Link to Opioid Addiction and Withdrawal

One of the reasons 7-OH and kratom appeal to users is their perceived potential to treat opioid use disorder (OUD) and ease opioid withdrawal. Anecdotally, kratom users report self-managing addiction and withdrawal symptoms using kratom-based products.

While this may suggest a harm-reduction role, the science is mixed. Clinical evidence supporting kratom for OUD is lacking, and the risk of developing a new form of dependence on kratom and 7-OH is substantial. Repeated use may lead to tolerance, withdrawal, and eventual addiction, especially when 7-OH concentrations are elevated through synthetic processing.

Furthermore, studies suggest that 7-OH can be reversed by naloxone, an opioid receptor competitive antagonist, further supporting its opioid-like mechanism and reinforcing the potential for abuse and dependency.[6]

Regulatory Status and Legal Landscape

As of 2026, kratom remains unregulated at the federal level, though some states and municipalities have taken independent action to ban or restrict sales. This regulatory gray area allows kratom products containing 7-OH to be widely sold — especially in gas stations, smoke shops, and vape stores.

The FDA has not approved kratom or 7-OH for any medical use, warning that the marketing of these products is often misleading and illegal. The agency continues to push for more research and regulatory oversight.

Why 7-OH Is a Particular Concern

Several factors contribute to the increasing scrutiny of 7-OH:

1. Potency: It is significantly more potent than mitragynine and traditional opioids in some cases.
2. Unregulated Access: Consumers can unknowingly access potentially dangerous doses.
3. Misuse Potential: Individuals seeking to self-medicate or experience euphoria may misuse kratom or concentrated forms of 7-OH.
4. Lack of Quality Control: Products often lack labeling, dosage guidelines, or purity assurance.

The Need for Caution and Consultation

Despite its medicinal chemistry profile and anecdotal use in pain and mood disorder management, 7-OH is not without risks. Consumers should consult with healthcare professionals before using kratom or related compounds, especially if they are pregnant, have pre-existing health conditions, or are using other medications.

Get Connected to Help for 7-OH Abuse and Addiction

7-hydroxymitragynine, or 7-OH, is a powerful compound derived from the kratom plant that interacts with opioid receptors in ways that mimic traditional opioids like morphine. While some seek it for relief from pain, anxiety, or opioid withdrawal, the risks — including respiratory depression, dependency, and liver toxicity — make it a substance of particular concern for public health officials.

As products containing 7-OH continue to flood gas stations, smoke shops, and vape stores, often marketed through food, drink mixes, or tablets, the need for regulation, research, and public education becomes more urgent.

If you or someone you know is struggling with kratom or opioid dependence, contact Eleve Behavioral Health for support. We can help you overcome kratom and opioid addiction using evidence-based substance abuse treatment methods like medication-assisted treatment and behavioral therapy.

FAQ: Understanding 7-OH and Kratom Products

1. How can I tell if a product contains 7-OH or synthetic concentrations of it?

Most over-the-counter kratom products do not disclose specific alkaloid levels, including 7-OH. Look for third-party lab testing (COAs – Certificates of Analysis) from reputable brands. If a product boasts “extra strength,” “enhanced,” or “extract,” it’s more likely to contain synthetically concentrated levels of 7-OH or other modified compounds.

2. Are there any safe or therapeutic doses of 7-OH?

There is currently no medically approved dosage for 7-OH, and the FDA has not endorsed its therapeutic use. Because potency can vary widely between products and individuals, what is “safe” for one person may cause adverse events in another. Medical supervision is essential if kratom is being considered for any therapeutic purpose.

3. Is 7-OH addictive on its own, or only in combination with other kratom alkaloids?

7-OH has demonstrated opioid receptor activity similar to morphine and is capable of producing dependency when used repeatedly, even independently. Its presence, especially in concentrated or isolated form, increases the risk of addiction, especially without the balancing effects of other alkaloids found in raw kratom leaves.

4. Can 7-OH be detected in drug tests?

Standard workplace drug tests (e.g., SAMHSA 5-panel) do not screen for kratom or 7-OH. However, specialized drug testing can detect mitragynine and its metabolites, including 7-OH. These tests are often used in legal, clinical, or research settings.

5. Why is 7-OH sometimes included in kratom extracts instead of mitragynine?

Manufacturers may favor 7-OH in extracts because it delivers stronger opioid-like effects at lower doses, increasing product potency. However, this raises regulatory and health concerns, as it also increases the likelihood of side effects, dependency, and overuse.

6. Is there any medical research exploring therapeutic uses of 7-OH or kratom?

Yes, emerging research in medicinal chemistry is exploring kratom alkaloids for potential treatment of pain, opioid use disorder, and mood disorders, among others. However, these are preclinical or early-phase studies, and no formulations of kratom or 7-OH have yet received FDA approval for any medical indication.

References:

1. ACS Publications: 7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects
2. The Food and Drug Administration (FDA): 7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat 
3. The Food and Drug Administration (FDA): FDA and Kratom
4. The Centers for Disease Control and Prevention (CDC): Unintentional Drug Overdose Deaths with Kratom Detected — 27 States, July 2016– December 2017
5. The National Library of Medicine (NLM): The Big Number: 1,807 calls to poison control centers about herbal supplement kratom
6. CPC Emergency Medicine: Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal